NCT02184052View on ClinicalTrials.gov

Safety and Efficacy of Mobic® Ampoules in the Initiation of Treatment of Painful Exacerbations of Osteoarthritis, Rheumatoid Arthritis and Other Similar Painful Inflammatory Conditions

CompletedOBSERVATIONAL
Enrollment

121

Participants

Timeline

Start Date

July 31, 2003

Primary Completion Date

March 31, 2005

Conditions
Arthritis, Rheumatoid
Interventions
DRUG

Meloxicam

7.5 mg or 15 mg

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02184052 - Safety and Efficacy of Mobic® Ampoules in the Initiation of Treatment of Painful Exacerbations of Osteoarthritis, Rheumatoid Arthritis and Other Similar Painful Inflammatory Conditions | Biotech Hunter | Biotech Hunter